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ABSTRACT
Objective: It is uncertain whether migraine prevalence
has increased in modern society. The aim of this study
was to assess any change in migraine prevalence over
an 8-year period among the adult population in
Denmark.
Design: Prospective longitudinal population-based
study.
Setting: 30 000 twin individuals were invited to
participate in two cross-sectional questionnaire
surveys containing validated questions to diagnose
migraine in 1994 and 2002. The twins are
representative of the Danish population with regard to
migraine and other somatic diseases.
Participants: The 1994 cohort comprised 28 571 twin
individuals aged 12e41 years and the 2002 cohort
31 865 twin individuals aged 20e71 years.
Outcome measures: Sex-, age- and subtype-specific
incidence and lifetime prevalence as well as 1-year
prevalence of migraine.
Results: 1-year prevalence in 2002 was 12.3% for
migraine, 4.1% for migraine with aura and 8.2% for
migraine without aura. Lifetime prevalence of migraine
was 16.1% in 1994 (aged 12e41 years) and 25.2% in
2002 (aged 20e71 years). Lifetime prevalence of
migraine for age 20e41 was increased from 1994
to 2002 (18.5% vs 24.5%) by 32.2% (95% CI 27.0%
to 37.3%; p<0.001). The difference was primarily
seen in the population older than 32 years. The
increase was especially evident in migraine with
aura (5.6% vs 9.4%, p<0.001) but also
a significant increase in migraine without aura was
found (13.0% vs 15.1%, p<0.001). Eight-year period
incidence rate of migraine was 0.141 corresponding to
an average annual incidence rate of 17.6 per 1000
person-years.
Conclusions: Lifetime prevalence of migraine in
Denmark increased substantially from 1994 to 2002.
Part of the increase may be due to increased medical
consultation resulting in increased rate of physician
diagnosis or awareness due to previously participation
in the 1994 survey. It is pertinent to study the
environmental causes of the increase and to
implement preventive measures.
INTRODUCTION
In 2001, migraine was ranked by the WHO as
the 19th of disabling diseases1 causing great
societal costs. In 2010, the total societal cost
in Europe was estimated to be €18.5 billion
per year for the 50 million migraine
sufferers.2 Migraine prevalence has been
assessed in several large-scale population-
based studies,3 4 but studies of incidence are
sparse. It is uncertain whether migraine
prevalence has increased in modern society.
Replicate studies of migraine prevalence in
the adult population using the same meth-
odology at all evaluations showed conflicting
results.5e9 Furthermore, only few studies
have distinguished between migraine with
aura (MA) and migraine without aura (MO).
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- Has migraine prevalence increased in modern
society?
Key messages
- Self-reported migraine prevalence increased
substantially in the Danish young adult
population.
- Sex- and age-specific prevalence and incidence
of migraine and its subtypes were estimated in
a large population-based sample.
Strengths and limitations of this study
- Large sample size made it possible to differen-
tiate between migraine with aura and migraine
without aura using the validated diagnostic
questions and furthermore subdivide between
men and women and to distinguish between age
groups.
- The validation of the two questions used to
identify migraine cases showed that self-reported
migraine was only correct in 74.5% of cases, and
furthermore, approximately 23.8% of the
migraine patients were not identified. Thus, our
estimates would tend to be conservative.
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Open Access Research
‘The Danish Twin Omnibus 1994 and 2002’ were
questionnaire studies among almost 30 000 and 35 000
twin individuals, respectively.10 11 Both studies used the
same validated questions to diagnose migraine and its
subtypes. In the present publication, the twin status is
disregarded and the material is presented as a random
sample from the Danish population, which is acceptable
since these twins are representative of the whole Danish
population with regard to migraine.12
The aim of our study was to estimate sex-, age- and
subtype-specific incidence and lifetime prevalence as
well as 1-year prevalence of migraine and to assess any
change in migraine prevalence over an 8-year period
among the young adult population in Denmark.
MATERIALS AND METHODS
The study populations were based on twin cohorts
enrolled in the Danish Twin Registry, one of the oldest
and most complete population-based twin registries in
the world.10 The ascertainment of twins enrolled in this
study was done using the Danish Civil Registration
System as primary source. This system had since 1 April
1968 registered all persons living in Denmark.10 11 13 The
twin cohorts from 1953 to 1982 were identified in 1991
by the mother assuming that a woman had twins if she
gave birth to more than one child within three consec-
utive days.14 Identification of twins born between 1931
and 1952 was based on an algorithm extracting all
persons born on the same date, in the same parish and
with the same historical surname.10 The Danish Twin
Registry is validated and representative of the Danish
population as a whole.12 15e17 The lifetime and 1-year
prevalence of migraine did not differ in monozygotic
twins, dizygotic twins and single individuals.12 The twins
were therefore regarded as single individuals in the
present study.
The ‘Twin Omnibus 1994’ comprised twin individuals
from the cohorts 1953 to 1982 and the ‘Twin Omnibus
2002’ twin individuals from the cohorts 1931 to 1982. The
questionnaires investigated self-reported migraine and the
cases were identified based on the following questions:
1. Have you ever had migraine?
2. Have you ever had visual disturbances that lasted from
5 to 60 min and were succeeded by a headache?
Subjects were classified as having migraine if they
answered ‘yes’ to question 1. The second question was
to determine whether they had MA or MO. MA was
defined as subjects answering ‘yes’ to both questions and
MO was defined as subjects answering ‘yes’ to question 1
and ‘no’ to question 2. Subjects answering ‘no’ to
question 1 were considered healthy. Any questionnaires
containing blanks in these two questions were excluded
for the purpose of the present study. Validation of the
screening questions showed that it was possible to iden-
tify 76% of all subjects with migraine, 85% of all with MA
and 72% of all with MO. A detailed description of the
validation of screening questions has been published
elsewhere.18
In the survey from 2002, participants who answered yes
to question 1 were asked to specify whether they had had
migraine in the past year or not. This was not a part of
the 1994 survey; therefore, 1-year prevalence was only
estimated in 2002. The 1-year prevalence rate was
calculated as the number of subjects reporting that they
had had migraine in the past year divided by the total
number of subjects, and the lifetime prevalence rate as
the number of subjects reporting migraine in the past
year or before that divided by the total number of
subjects. Because the age range of the two cohorts was
different in 1994 and 2002, comparison of the two
prevalence rates was conducted only for twins aged
20e41 years. Comparison of the two groups was
performed with c2 test. The incidence cases were
defined as subjects reporting migraine in 2002 who did
not report migraine in 1994. The average annual inci-
dence rate was estimated as per 1000 person-years (PYs).
Prevalence and incidence estimates were stratified by
sex, age and subtypes. Data analyses were performed
with PASW Statistics V.18.0 by SPSS Inc.
RESULTS
Participants
Of all the subjects who returned the questionnaire in
1994, 97.1% (n¼28 571) had answered both migraine
questions. More women (66.0%) had migraine than
men (34.0%), whereas a more even distribution of sex
was seen in the group without migraine (49% women
and 51% men). The migraine group was older than
the no-migraine group (men: median ¼30 vs 27 and
mean ¼29 vs 27; women: median ¼30 vs 26 and mean
¼29 vs 26).
In 2002, 91.2% (n¼31 865) of all returned question-
naires were complete with regard to both migraine
questions. There were more women (69.6%) than men
(30.4%) in the migraine group, whereas only little
difference was found in the group without migraine
(49% women and 51% men). The median and mean age
differed with 1 year between the migraine group and the
group without migraine (men: median and mean ¼45 vs
44; women: median ¼43 vs 42 and mean ¼44 vs 43).
1-year prevalence
The 1-year prevalence in 2002 was 12.3%. Table 1 shows
the sex- and subtype-specific prevalences. The age-
specific 1-year prevalence of migraine, MA and MO, is
shown in figure 1AeC. The prevalence peaked around
age 38e40 in both men and women. For MO, the 1-year
prevalence showed a plateau between age 25 and 40,
whereas for MA, a sharp peak was seen around age 40.
Lifetime prevalence
The lifetime prevalence was 16.1% in 1994 (age 12e41)
and 25.2% in 2002 (age 20e71). The sex- and subtype-
specific prevalence rates for both years are presented in
table 2. In 1994, the age-specific lifetime prevalence of
migraine in women peaked in the early 30s followed by
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a small decrease, whereas the prevalence in men showed
a plateau between age 27 and 41 (figure 2AeC). The
prevalence of MO peaked around age 27e34 in women
and around age 31 in men. The MA prevalence slowly
increased with age. In 2002, the prevalence of migraine
peaked around age 40 and slowly decreased (figure
3AeC). For MO, the prevalence increased to age 40
where it reached plateau. For MA, the prevalence
peaked around age 38.
Change in prevalence
In order to estimate possible changes in prevalence, we
compared the subjects aged 20e41 years, which
comprised 22 053 persons in the 1994 cohort and 14 810
persons in the 2002 cohort. The 2002 cohort was slightly
older than the 1994 cohort (median ¼32 vs 30, mean
¼31 vs 30 and 90% percentiles 21e41 vs 21e40). The
lifetime prevalence for age 20e41 was increased from
1994 to 2002 (18.5% vs 24.5%) by 32.2% (95% CI 27.0%
to 37.3%; p<0.001). The difference was primarily seen in
the population older than 32 years (figure 4AeC). The
increase was especially evident in MA (5.6% vs 9.4%,
p<0.001), but we also found a significant increase in MO
as well (13.0% vs 15.1%, p<0.001). The prevalence
increased significantly in women from 24.0% to 30.9%
and in men from 12.6% to 16.1%. The relative increase
was similar for both sexes (27.8% vs 28.8%).
Incidence
Nineteen thousand five hundred and eighty-six subjects
had completed both twin surveys with regard to
migraine. Sixteen thousand four hundred and forty-two
subjects aged 12e41 years did not report having
migraine in 1994. Of those, 2318 subjects reported
migraine in 2002 resulting in an 8-year period incidence
rate of 0.141 corresponding to an average annual inci-
dence rate of migraine of 17.6 per 1000 PYs. The inci-
dence rates of migraine and its subtypes are listed in
table 3. We did not find any significant difference in
incidence between age groups 20e29 and 30e39
(p¼0.0834) nor 30e39 and 40e49 (p¼0.0762); however,
a significantly higher incidence was found in the group
aged 20e29 than 40e49 (p¼0.0007). Decreasing inci-
dence rate with age was especially seen in MO subjects.
There were 2206 subjects reported having MO in 1994
who had also completed the 2002 survey. The average
annual incidence rate of MA in these subjects was 25.8
PYs (95% CI 23.5 to 28.3, n crude ¼456).
DISCUSSION
The present study demonstrated a significant increase of
self-reported migraine prevalence in the Danish young
adult population from 1994 to 2002. The increase was
especially evident in MA and the increase in MO was also
Table 1 Sex-specific 1-year prevalence rates of migraine, migraine with aura (MA) and migraine without aura (MO) in 2002
(31 865 subjects aged 20e71 years)
2002
Migraine MA MO
Rate (%) 95% CI n, crude Rate (%) 95% CI n, crude Rate (%) 95% CI n, crude
All subjects 12.3 11.9 to 12.7 3927 4.1 3.9 to 4.3 1307 8.2 7.9 to 8.5 2620
Women 16.5 15.9 to 17.2 2855 5.7 5.3 to 6.1 983 10.8 10.4 to 11.3 1872
Men 7.3 6.9 to 7.8 1072 2.2 2.0 to 2.5 324 5.1 4.8 to 5.5 748
Figure 1 (AeC) The age- and
sex-specific 1-year prevalence of
migraine and its subtypes in 2002.
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significant. The increase was primarily seen in the
population older than 32 years.
Migraine lifetime prevalence
The lifetime prevalence has been estimated in several
population-based studies with large variation between
11.2% and 27.5% in questionnaire-based studies and
between 12% and 19% in interview-based studies in the
developed countries.3 The variation seen may be due to
difference in methodology. One might wonder why the
prevalence of lifetime migraine in 2002 was unexpect-
edly high in our study compared with the lifetime prev-
alence in the other developed countries. However, when
comparing the prevalence found in other large-scale
comparable European population-based questionnaire
studies our results were similar; for references, see
Stovner and Andree.4 This was true for both men and
women. One explanation could be that patients in
Europe were more likely to receive a medical diagnosis
than for example in the USA.19 Very few studies have
estimated the lifetime prevalence of migraine subtypes.
A previous Danish study20 showed a higher lifetime
prevalence of MA than the one we found in 1994 (6% vs
4.8%). However, the prevalence of MO was lower than
ours (8% vs 11.3%). Another study found lower preva-
lence rates of both MA and MO, 3.3% and 7.1%.21 We
expected to see increasing lifetime prevalence with
advancing age; however, the prevalence was decreasing
after the fifth decade. A decrease was especially seen in
MA, whereas the prevalence in MO reached a plateau.
This is likely due to recall bias as discussed previ-
ously.22 23 MA patients tend to neglect having migraine
compared with MO patients because MA attacks are less
frequent and less severe.24 That may explain the
pronounced difference in MA and MO patients.
Is the migraine prevalence increasing?
We found a 32% increase in the lifetime prevalence of
migraine in a period of 8 years. Change in lifetime as
well as 1-year prevalence has previously been investigated
in replicate studies. A large-scale study investigating
subjects aged 12 years and older found that the lifetime
Figure 2 (AeC) The age- and
sex-specific lifetime prevalence of
migraine and its subtypes in 1994.
Table 2 Sex-specific lifetime prevalence rates of migraine, migraine with aura (MA) and migraine without aura (MO) in 1994
(28 571 subjects aged 11e41 years) and 2002 (31 865 subjects aged 20e71 years)
Migraine MA MO
Rate (%) 95% CI n, crude Rate (%) 95% CI n, crude Rate (%) 95% CI n, crude
1994
All subjects 16.1 15.6 to 16.6 4593 4.8 4.5 to 5.0 1368 11.3 10.9 to 11.7 3225
Women 20.5 19.8 to 21.3 3031 6.5 6.1 to 6.9 963 14.0 13.4 to 14.6 2068
Men 11.3 10.8 to 11.9 1562 2.9 2.7 to 3.2 405 8.4 7.9 to 8.9 1157
2002
All subjects 25.2 24.7 to 25.8 8044 9.7 9.3 to 10.0 3086 15.6 15.1 to 16.0 4958
Women 32.4 31.6 to 33.3 5597 13.1 12.6 to 13.7 2265 19.3 18.7 to 20.0 3332
Men 16.8 16.1 to 17.4 2447 5.6 5.2 to 6.0 821 11.1 10.6 to 11.7 1626
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prevalence of migraine increased significantly by 16%
over a period of 4 years in women (10.1% vs 11.7%,
p#0.01), but a non-significant decrease was seen in men
(4.3% vs 3.8%).6 The group of 25e54 years that is more
comparable with our study population also showed
a significant increase in women and a non-significant
increase in men. Our study showed a significant increase
in both sexes. The difference seen may be due to
different study population or sample size. A Danish study
investigating both lifetime and 1-year prevalence of
migraine from 1989 to 2001 found no significant
changes, as only a tendency towards an increase was
observed (14.5% vs 18.4%, difference 3.9, 95% CI
11.5 to 3.8 for the lifetime prevalence; 11.3% vs 15.5%,
difference 4.1, 95% CI 11.1 to 2.8 for the 1-year
prevalence).8 This increasing trend was also seen for
1-year prevalence in women (15.6% vs 23.5%, p¼0.14).
However, this study had a small sample size (n¼211 and
207) and must be interpreted with caution. A recent
large-scale population-based study found a small
increase in the 1-year prevalence (12.1% vs 13.2%,
p<0.001).9 A marked increase in 6 months prevalence
over a period of 28 years (1.9%e5.7%) was found in
a study investigating 7-year-old children.25 Other large-
scale studies demonstrated no change in migraine
prevalence over time.5 7 A true increase in prevalence
would be attributed to rising incidence. However, part of
the increase may also be due to rising public awareness
of migraine or increased medical consultation resulting
in an increased rate of physician diagnosis.26 27 We do
not know of any approaches to increase awareness of
migraine in Denmark. However, an increase in medical
consultation has been shown.28 Subjects born in
1953e1982 were invited to participate in both surveys.
Figure 4 (AeC) Comparison of
lifetime prevalence rates of 1994
with 2002 for subjects aged
20e41 years.
Figure 3 (AeC) The age- and
sex-specific lifetime prevalence of
migraine and its subtypes in 2002.
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This means that the group of subjects who did partici-
pate in both surveys would have experienced the
migraine questions already. It is possible that these
subjects became more aware of migraine to the second
survey. On balance, our data convincingly show an
increase in prevalence, but the size of the increase may
not be as high as our finding of 32%. Due to the short
time span of 8 years, this must be caused by environ-
mental factors and not by genes. Mutations cannot
increase the migraine prevalence so quickly in a general
population. Currently, we do not know about any
potential environmental factors or its nature or course.
Some factors, such as social economic status,5 smoking
and alcohol,29 have been suggested based on cross-
sectional studies, but to our knowledge, very few longi-
tudinal studies have investigated risk factors for
migraine. One cohort study reported that smokers have
a higher risk of developing self-reported migraine.30
Apparently, the need of more longitudinal studies is
wanted.
Migraine 1-year prevalence
Although our lifetime prevalence was high, the 1-year
prevalence was found to match the lower range of the
prevalence rates in Europe based on large-scale compa-
rable questionnaire studies (11.6% to 16.3%, 7.5% to
9.5% in men and 15.6% to 25% in women) as well as in
interview-based studies.4 Comparing the 1-year migraine
prevalence in 2002 with the lifetime prevalence in 2002,
we found that more than 50% reporting lifetime
migraine did not experience attacks during the last year.
This speaks for a favourable course of migraine. Only few
studies24 27 31e34 have investigated the 1-year prevalence
of migraine subtypes showing a range for MA of 0.6% to
3.7% in men and 3.6% to 10.8% in women and for MO
2% to 7.3% and 7.5% to 11.9%, respectively. Our prev-
alence estimates were similar to those found previously
in Denmark and the UK.24 33 The American Migraine
study revealed increasing prevalence in both male and
female subjects from age 12 until approximately age 40,
after which a decreasing prevalence was noted.35 This is
in keeping with our findings (see figure 1AeC).
Incidence
A great variation is found in the literature for the inci-
dence rate of migraine in the adult population (1.4e5.0
per 1000 PYs in men and 2.9e22 per 1000 PYs in
women).36e39 Our incidence rate in women is in
keeping with previous findings; however, the rate in men
is somewhat higher. A previous small-scale study in
Denmark found an incidence of 8.1 per 1000 PYs in 2001
in subjects aged 25e64 years.40 We found an annual
incidence rate of 17.6 per 1000 PYs for migraine. The
difference seen could be due to different methodology
or that our population was younger (20e49 years old).
Methodological considerations
It was possible in this study to differentiate between MA
and MO because of the use of validated diagnostic ques-
tions.18 Furthermore, it was possible to subdivide between
men and women and to distinguish between age groups
because of the large sample size. However, the present
study also has weaknesses. The validation of the two
questions used to identify migraine cases showed that
self-reported migraine was only correct in 74.5% of cases,
and furthermore, approximately 23.8% of the migraine
subjects were not identified. Thus, our estimates would
tend to be conservative. However, the sensitivity of our
questions was higher than the sensitivity of a questionnaire
modified according to the criteria of the International
Classification of Headache Disorders 2nd edition9; there-
fore, our questions should be valid as a tool for identifying
migraine and determining the prevalence and incidence.
CONCLUSIONS
Our most important finding was a substantial increase in
the lifetime prevalence of self-reported migraine in
Denmark from 1994 to 2002 confirming previous
studies. Part of the increase may be due to increased
medical consultation resulting in an increased rate of
physician diagnosis or awareness due to previous
participation in the 1994 survey. It seems pertinent to
study the causes of the increase and to implement
preventive measures.
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